Independent studies have shown that M7824 depletes soluble TGF-ꞵ and increases T-cell trafficking into tumor sites along with antigen-specific CD8+ T-cell mediated cytolytic activity, but it also enforces changes in the microenvironment in favor of the immune system to potentially increase the efficacy of cancer vaccines 148, 149. The gene discussed is CD8A; the disease is neoplasm.